InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,655.00
+46.00 (2.86%)
Sep 29, 2026, 2:24 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 190.6 million as of September 28, 2026. Its market cap has decreased by -29.32% in one year.
Market Cap
190.60M
Enterprise Value
326.77M
Revenue
270.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,655.00
ChartMarket Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.36M to 190.60M, an increase of 2,895.71%. That is a compound annual growth rate of 24.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 190.60M | 7.71% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.28B |
| Rafa Laboratories | 1.78B |
| BrainsWay | 1.61B |
| Novolog (Pharm-Up 1966) | 429.13M |
| Bonus BioGroup | 214.94M |
| Golden House | 162.15M |
| Rekah Pharmaceutical Industry | 130.70M |